Our guest in this episode is Dr. Ilham Kadri, the CEO of Syensqo, a global speciality chemicals company listed in Brussels. In 2023, Ilham led the spin-off of Syensqo from Solvay, the 160-year old Belgian chemicals conglomerate.

In this interview, Ilham discusses the strategic rationale behind the decision to split Solvay into two separate entities, highlighting the aim to unlock the full potential of both companies. She explains how Solvay, a historic leader in commodity chemicals, and Syensqo, a new entity focused on specialty chemicals, were positioned to pursue their unique growth strategies. The conversation delves into the meticulous planning and execution required for the separation, emphasizing the importance of stakeholder engagement and maintaining operational continuity during a volatile global environment.

She highlights Syensqo's focus on innovation and sustainability, detailing its ambitious goals for carbon neutrality and its role in advancing technological solutions. The episode also touches on the broader implications of the spin-off, including the strategic benefits of being a publicly listed company and the impact on stakeholders, from employees to investors. Dr. Kadri's leadership and vision provide a comprehensive view of the complexities involved in creating two independent champions from a long-standing conglomerate.

Disclaimer: The discussion in this episode is not financial advice, nor an investment recommendation, nor a solicitation to buy or sell any financial instruments or an offer for financial services or any other transaction. The information contained in the recording has no contractual value and is intended for informational purposes only. Amundsen Investment Management and the participants in this podcast may have holdings in the companies being discussed. Any views expressed are those of the guests only, and not of Amundsen Investment Management.

In this episode we welcome Anne Ross, EMEA Equity Syndicate Manager at Fidelity Management and Research, our first guest from the buy-side. With her background at JP Morgan and now on the buy-side, Anne provides invaluable insights into the IPO process, from the role of bookrunners and strategic selection of banks, to the importance of understanding investor types and maintaining a strong shareholder base post-IPO, offering her view of what it takes to successfully navigate the public markets.

Anne also delves into the evolving nature of IPOs, highlighting the impact of market trends and the necessity of aligning management incentives with shareholder interests. She emphasizes the significance of timing and strategic planning, advising companies to be well-prepared and adaptable. Whether you're a company considering going public or an investor seeking to understand the IPO landscape better, this episode is packed with practical advice and expert insights that are sure to enhance your understanding of the IPO journey.

Disclaimer: The discussion in this episode is not financial advice, nor an investment recommendation, nor a solicitation to buy or sell any financial instruments or an offer for financial services or any other transaction. The information contained in the recording has no contractual value and is intended for informational purposes only. Amundsen Investment Management and the participants in this podcast may have holdings in the companies being discussed. Any views expressed are those of the guests only, and not of Fidelity Management & Research or Amundsen Investment Management.

Norva24 is a leader in underground infrastructure maintenance services in Northern Europe – that is the maintenance of all the infrastructure related to sewage and waste water. It is a Norwegian company, that has grown through the acquisition of smaller players over the years. In 2021, Henrik Damgaard, the company's CEO at the time, led Norva24 to an IPO in Stockholm, joining a number of other so-called ‘M&A compounders’ listed there – but all in different industries.

With Henrik, we discuss all the specificities of the Norva24 IPO, such as his experience of managing an IPO in a new industry to investors, listing a Norwegian company in Sweden, with a Danish CEO, and the specificities of listing an M&A compounder.

Disclaimer: this discussion is not financial advice, nor an investment recommendation, nor a solicitation to buy or sell any financial instruments, or an offer for financial services or any other transaction. The information contained in the recording have no contractual value and are destined for an informational purpose only. Amundsen Investment Management and the participants on this podcast may have holdings in the companies being discussed.